Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.1.303NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
AA.7ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
AA.7ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AA.7ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AA.7NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-17121.6US
B.1.173ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.173ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.173ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.173NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.362.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.362.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.362.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.362.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.177.48ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.177.48ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.177.48ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.177.48NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.36.9ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.36.9ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.36.9ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.36.9NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.520ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.520ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.520ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.520NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.36.38ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.36.38ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.36.38ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.36.38NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.521ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.521ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.521ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.521NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.383ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.383ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.383ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.383NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.117ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.117ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.117ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.117NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.157ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.157ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.157ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.157NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.187ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.187ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.187ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.187NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.160.30ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used